Aurobindo Pharma Limited — Others, 06-08-2025: Copy of Newspaper Publication

Aurobindo Pharma has announced its financial results for the quarter ended June 30, 2025. On a consolidated basis, the company reported total income from operations of ₹7,881.14 Cr. Profit before tax stood at ₹1,208.1 Cr, while profit after tax was ₹824.2 Cr. The standalone results show a total income of ₹2,848.17 Cr, profit before tax of ₹750.09 Cr, and profit after tax of ₹559.13 Cr. These figures provide stakeholders with key performance insights for the recent quarter.